Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia (Q39670318)
Jump to navigation
Jump to search
scientific article published on December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia |
scientific article published on December 2003 |
Statements
1 reference
Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia (English)
1 reference
Bengt R Danielsson
1 reference
Anna-Carin Sköld
1 reference
Alf Johansson
1 reference
Birgitta Dillner
1 reference
Bo Blomgren
1 reference
1 December 2003
1 reference
1 reference
193
1 reference
2
1 reference
168-176
1 reference
Identifiers
1 reference
1 reference